Chronic Liver Failure

Clinical Trial Of "Artificial Liver" Uses Albumin Dialysis In Treatment

Published in Hepatitis Weekly, August 20th, 2001

Adding albumin to a dialysis solution may help patients wake up faster from coma due to chronic liver failure, according to researchers at Northwestern University Medical School, Illinois.

Scientists are conducting a controlled study of a new "artificial liver" that uses albumin, a protein that is produced naturally by the body and is a major component of human blood plasma, to remove toxins from the blood of patients in chronic liver failure who are comatose.

The new artificial liver is called a molecular adsorbent recirculation system, or MARS. With MARS, toxic substances in the blood bind to the albumin, cross into the dialysis solution, and are...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-08-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry